In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dynavax Europe

Division of Dynavax Technologies Corp.

Latest From Dynavax Europe

Deals (04/2006)

Deals Shaping the Medical Industry (1/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Germany Welcomes Its First Public Biotech Firm

On March 9, 1999 Morphosys became the first German biotech to go public on the Neuer Markt. Plenty of companies are right behind it. But will the German appetite for public companies grow quickly cloyed?
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Rhein Biotech Dusseldorf
  • Rhein Biotech GMBH
  • Dynavax Dusseldorf
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Dynavax Technologies Corp.
  • Senior Management
  • Zbigniew Janowicz, PhD, CEO
    Petra Zimmer, CFO
    Oliver Bartelsen, PhD, Dir., Bus. Dev.
  • Contact Info
  • Dynavax Europe
    Phone: (49) 211 7 58 45 0
    Eichsfelder Strasse 11
    Dusseldorf, D-40595